Literature DB >> 21131894

Patent ductus arteriosus ligation alters pulmonary gene expression in preterm baboons.

Nahid Waleh1, Donald C McCurnin, Bradley A Yoder, Philip W Shaul, Ronald I Clyman.   

Abstract

Ibuprofen-induced ductus closure improves pulmonary mechanics and increases alveolar surface area in premature baboons compared with baboons with a persistent patent ductus arteriosus (PDA). Ibuprofen-treatment has no effect on the expression of genes that regulate pulmonary inflammation but does increase the expression of alpha-ENaC (the transepithelial sodium channel that is critical for alveolar water clearance). Although ligation eliminates the PDA, it does not improve pulmonary mechanics or increase alveolar surface area. We used preterm baboons (delivered at 67% of term gestation and ventilated for 14 d) to study whether the lack of beneficial effects, after PDA ligation, might be due to alterations in pulmonary gene expression. We found no differences in ventilation or oxygenation indices between animals that were ligated (n = 7) on day of life 6 and those that had a persistent PDA (n = 12) during the entire 14 d study. In contrast with no intervention, PDA ligation produced a significant increase in the expression of genes involved with pulmonary inflammation (COX-2, TNF-α, and CD14) and a significant decrease in alpha-ENaC sodium channel expression. We speculate that these changes may decrease the rate of alveolar fluid clearance and contribute to the lack of improvement in pulmonary mechanics after PDA ligation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21131894      PMCID: PMC3065199          DOI: 10.1203/PDR.0b013e3182084f8d

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  48 in total

1.  Patent ductus arteriosus increases lung fluid filtration in preterm lambs.

Authors:  G Alpan; R Scheerer; R Bland; R Clyman
Journal:  Pediatr Res       Date:  1991-12       Impact factor: 3.756

2.  Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia.

Authors:  K Tullus; G W Noack; L G Burman; R Nilsson; B Wretlind; A Brauner
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

3.  A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth.

Authors:  G Cassady; D T Crouse; J W Kirklin; M J Strange; C H Joiner; G Godoy; G T Odrezin; G R Cutter; J K Kirklin; A D Pacifico
Journal:  N Engl J Med       Date:  1989-06-08       Impact factor: 91.245

4.  Improved lung compliance after ligation of patent ductus arteriosus in hyaline membrane disease.

Authors:  C M Naulty; S Horn; J Conry; G B Avery
Journal:  J Pediatr       Date:  1978-10       Impact factor: 4.406

5.  Lung compliance in newborns with patent ductus arteriosus before and after surgical ligation.

Authors:  T Gerhardt; E Bancalari
Journal:  Biol Neonate       Date:  1980

6.  Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates.

Authors:  P Groneck; B Götze-Speer; M Oppermann; H Eiffert; C P Speer
Journal:  Pediatrics       Date:  1994-05       Impact factor: 7.124

7.  Early death due to defective neonatal lung liquid clearance in alpha-ENaC-deficient mice.

Authors:  E Hummler; P Barker; J Gatzy; F Beermann; C Verdumo; A Schmidt; R Boucher; B C Rossier
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

8.  Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome.

Authors:  P Kääpä; P Lanning; M Koivisto
Journal:  Acta Paediatr Scand       Date:  1983-03

9.  Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.

Authors:  W M Gersony; G J Peckham; R C Ellison; O S Miettinen; A S Nadas
Journal:  J Pediatr       Date:  1983-06       Impact factor: 4.406

10.  Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome. Effects of pulmonary compliance and ventilation.

Authors:  J L Stefano; S Abbasi; S A Pearlman; M L Spear; K L Esterly; V K Bhutani
Journal:  Am Rev Respir Dis       Date:  1991-02
View more
  11 in total

1.  Treatment and Nontreatment of the Patent Ductus Arteriosus: Identifying Their Roles in Neonatal Morbidity.

Authors:  Ronald I Clyman; Melissa Liebowitz
Journal:  J Pediatr       Date:  2017-07-11       Impact factor: 4.406

2.  Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.

Authors:  Melissa Liebowitz; Ronald I Clyman
Journal:  J Pediatr       Date:  2017-04-07       Impact factor: 4.406

Review 3.  The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia.

Authors:  Ronald I Clyman
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

4.  Liver disease after intensive care of premature baboons: histopathologic observations.

Authors:  Jay Kerecman; Anupamjit Mehrotra; Zachary Goodman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-08       Impact factor: 2.839

Review 5.  Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all?

Authors:  Ronald I Clyman; James Couto; Gail M Murphy
Journal:  Semin Perinatol       Date:  2012-04       Impact factor: 3.300

6.  Dopamine-resistant hypotension and severe retinopathy of prematurity.

Authors:  Melissa Catenacci; Shogo Miyagi; Andrea C Wickremasinghe; Sarah Scarpace Lucas; Alejandra G de Alba Campomanes; William V Good; Ronald I Clyman
Journal:  J Pediatr       Date:  2013-03-01       Impact factor: 4.406

7.  Neurodevelopmental outcomes following two different treatment approaches (early ligation and selective ligation) for patent ductus arteriosus.

Authors:  Andrea C Wickremasinghe; Elizabeth E Rogers; Robert E Piecuch; Bridget C Johnson; Suzanne Golden; Anita J Moon-Grady; Ronald I Clyman
Journal:  J Pediatr       Date:  2012-07-13       Impact factor: 4.406

Review 8.  Should we definitively abandon prophylaxis for patent ductus arteriosus in preterm new-borns?

Authors:  Vassilios Fanos; Michele Pusceddu; Angelica Dessì; Maria Antonietta Marcialis
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

9.  The timing of surgical ligation for patent ductus arteriosus is associated with neonatal morbidity in extremely preterm infants born at 23-25 weeks of gestation.

Authors:  Se In Sung; Soo Young Choi; Jae Hyun Park; Myung Sook Lee; Hye Soo Yoo; So Yoon Ahn; Yun Sil Chang; Won Soon Park
Journal:  J Korean Med Sci       Date:  2014-04-01       Impact factor: 2.153

Review 10.  Patent ductus arteriosus ligation and adverse outcomes: causality or bias?

Authors:  Dany E Weisz; Patrick J McNamara
Journal:  J Clin Neonatol       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.